Please provide your email address to receive an email when new articles are posted on . The BD MAX Respiratory Viral Panel detected and differentiated between influenza A and B respiratory syncytial ...

Becton, Dickinson and Co.’s (BD) diagnostic tool that can check for COVID-19, the flu or respiratory syncytial virus (RSV) has been available in certain European countries since last year. Now, it’s ...

The FDA cleared for commercial distribution a diagnostic panel that tests for multiple respiratory viral and bacterial infections on Feb. 3. The BioFire Spotfire Respiratory Panel is the first ...

FRANKLIN LAKES, N.J., Aug. 1, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) ...

You may have noticed that more and more people are testing positive for COVID-19 after using a rapid test to swab their throats. The trend took off on Twitter this past week, and unlike most of the ...

After receiving one of a dwindling number of COVID-era FDA emergency authorizations earlier this year, BD has converted its combination respiratory virus test to a full regulatory green light. The ...

The COVID-19 pandemic yielded important advances in testing for respiratory viruses, but it also exposed important unmet needs in screening to prevent the spread of infections in high-risk settings.

(RTTNews) - PerkinElmer Inc. (PKI) said Thursday that it has received an emergency use authorization from the U.S. Food and Drug Administration for the PKamp Respiratory SARS-CoV-2 RT-PCR Panel 1 ...

In a recent study published in the journal Nature, researchers used nasopharyngeal swabs and single-cell ribonucleic acid (RNA) sequencing (scRNAseq) to characterize the populations of immune cells in ...

Scientists and policymakers have devised many strategies to reduce the emergence and spread of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causal agent of the ongoing ...

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the PKamp™ Respiratory ...